QR kód

Direct Antiviral Agents May Obviate the Need for Liver Transplantation for HCV Cirrhosis by the End of the Decade

<b>Background:</b> Hepatitis C viral infection (HCV) has historically been a leading indication for liver transplantation (LTx), primarily due to its progression to cirrhosis and hepatocellular carcinoma (HCC). However, the advent of direct-acting antiviral agents (DAAs) over a decade ago has revolu...

Celý popis

Uloženo v:
Hlavní autoři: Nathanael Haynes, Allyson Cochran, Maria Baimas-George, William Archie, Namratha Mylarapu, Vincent Casingal, Jose Soto, Philippe Zamor, Andrew DeLemos, Paul Schmeltzer, Steven Zacks, Natasha Adlakha, Roger Denny, Mark Russo, Lon Eskind, Dionisios Vrochides
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2026-04-01
Edice:Surgeries
Témata:
transplant
hepatitis C
hepatocellular carcinoma
direct-acting antivirals
On-line přístup:https://www.mdpi.com/2673-4095/7/2/51
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky